Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor NK Cell Infusion After Haplo-HCT in Refractory Acute Leukemia
NCT01795378Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Feb 2013
- Primary completion
- May 2015
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of donor natural killer cell infusion in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Asan Medical Center. Started Feb 2013; status: completed.
02
Drugs
donor natural killer cell infusion
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01795378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01795378.